PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden. [electronic resource]
- European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Dec 2019
- 105070 p. digital
Publication Type: Journal Article
1879-0720
10.1016/j.ejps.2019.105070 doi
Animals Antineoplastic Agents--administration & dosage Biological Transport Breast Neoplasms--drug therapy Cell Line, Tumor Cell Survival--drug effects Curcumin--administration & dosage Dogs Drug Compounding--methods Drug Liberation Drug Therapy, Combination--methods Female Humans Lipid Bilayers--chemistry Lysosomes--metabolism Mice, Inbred BALB C Mice, Nude Mitochondria--metabolism Nanocapsules--chemistry Paclitaxel--administration & dosage Polyethylene Glycols--chemistry Porosity Rats, Sprague-Dawley Silicon Dioxide--chemistry Surface Properties Tumor Burden--drug effects